Stock 7AL ALLIGATOR BIOSCIENCE AB
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Alligator Bioscience AB Deutsche Boerse AG

Equities

7AL

SE0000767188

Market Closed - Deutsche Boerse AG
Other stock markets
 13:22:04 31/05/2024 BST 		5-day change 1st Jan Change
0.093 EUR +18.62% Intraday chart for Alligator Bioscience AB +19.54% +64.31%
05-23 Alligator Bioscience to Present Positive Phase 2 Mitazalimab Data in Pancreatic Cancer at 2024 ASCO Annual Meeting CI
05-21 US FDA Grants Investigational New Drug Clearance for Alligator Bioscience's Late-stage Gastric Cancer Treatment Trial MT

Other languages

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Alligator Bioscience to Present Positive Phase 2 Mitazalimab Data in Pancreatic Cancer at 2024 ASCO Annual Meeting
Alligator Bioscience to Present Positive Phase 2 Mitazalimab Data in Pancreatic Cancer at 2024 ASCO Annual Meeting
US FDA Grants Investigational New Drug Clearance for Alligator Bioscience's Late-stage Gastric Cancer Treatment Trial
Alligator Bioscience : Announces Henlius Biotech has Received FDA IND Clearance for Phase 3 Initiation to Evaluate HLX22 (AC101) in 1st Line HER2+ Advanced Gastric Cancer
Alligator Bioscience’s Announces Henlius Biotech has Received FDA IND Clearance for Phase 3 Initiation to Evaluate HLX22 (AC101) in 1st Line HER2+ Advanced Gastric Cancer
Alligator Bioscience : Announces Publication Highlighting Potential of Next Generation CD40 Agonists in Peer Reviewed Medical Journal "Expert Opinion on Biological Therapy"
Alligator Bioscience Announces Publication Highlighting Potential of Next-Generation CD40 Agonists in Peer-Reviewed Medical Journal "Expert Opinion on Biological Therapy"
Alligator Bioscience Announces Initiation of an Investigator-Initiated Initiation of Phase 1 Clinical Study of Intratumoral Mitazalimab in Locally Advanced Pancreatic Cancer
Alligator Bioscience Announces Initiation of an Investigator-Initiated Phase 1 Clinical Study of Mitazalimab in Local Advanced Pancreatic Cancer
Bulletin from the annual general meeting in Alligator Bioscience AB on 7 May 2024
Alligator Bioscience Q1 2024 - The Next Catalyst Will Be the 18-month Readout
Transcript : Alligator Bioscience AB, Q1 2024 Earnings Call, May 06, 2024
Alligator Bioscience AB reports financial results for Q1 2024 and provides a business update
Alligator Bioscience AB Reports Earnings Results for the First Quarter Ended March 31, 2024
BioStock: Orion option exercise triggers milestone payment for Alligator
Change in number of shares and votes in Alligator Bioscience AB
Alligator Bioscience and Orion Corporation announce exercise of development option under 2021 Immuno-oncology Research Collaboration and License Agreement
Alligator Bioscience and Orion Corporation Announces Exercise of Development Option Under 2021 Research Collaboration and License Agreement
Last day of trading in paid subscribed units (Sw. BTU) in Alligator
Alligator publishes outcome in rights issue
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ATORX Stock
  4. 7AL Stock
  5. News Alligator Bioscience AB
  6. Other languages